Skip to content

Medical-device intelligence

Abbott: selected FDA company records

Connect selected Abbott source names with their classification, clearance, and recall histories.

Included source names

Membership is based on Abbott Laboratories, 2025 Form 10-K, Exhibit 21 ↗, as of Jan 31, 2026. Mapping checked Nov 19, 2026. This is a selected research group, not a complete corporate family or a statement of current ownership.

  • Abbott Laboratories
  • Abbott Diabetes Care Inc.
  • Abbott Point of Care Inc.
  • Abbott Cardiovascular Systems Inc.
  • Abbott Molecular Inc.
  • Abbott Vascular Inc.

Matching FDA profiles

Names without a matching profile contribute no records. Punctuation and case are normalized; legal-name variants and private customer aliases are not merged automatically. Each underlying record is counted once.

Record activity in this scope

978 clearance records and 344 recall records in the covered releases, across 5 source company names and 318 product codes. Dated history runs from Sep 16, 1976 to Sep 23, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202505
December 202500
January 202600
February 202600
March 202600
April 202613
May 202600
June 202620
July 202600
August 202600
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

1,322 matching records
Device / recordCompany in FDA recordSourceSource date
Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.Z-1349-2023 · OOIAbbott Molecular, Inc.RecallApr 6, 2023FDA classification date
Alinity m STI AssayK222379 · QEPAbbott Molecular, Inc.510(k)Mar 3, 2023FDA decision date
FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring SystemK222447 · QBJAbbott Diabetes Care, Inc.510(k)Mar 3, 2023FDA decision date
Traumatic brain injury (TBI) testK223602 · QATAbbott Laboratories510(k)Mar 2, 2023FDA decision date
FreeStyle Libre 2 System, FreeStyle Libre 3 SystemK223537 · QLGAbbott Diabetes Care, Inc.510(k)Feb 21, 2023FDA decision date
Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplifica…Z-1009-2023 · OOIAbbott Molecular, Inc.RecallJan 20, 2023FDA classification date
Alinity Reaction Vessels, REF: 06P1401, for use with Alinity i Systems; ARCHITECT Reaction VesselsZ-0958-2023 · DHAAbbott LaboratoriesRecallJan 17, 2023FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096Z-0739-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090Z-0740-2023 · QJRAbbott Molecular, Inc.RecallDec 20, 2022FDA classification date
Alinity m System, REF 08N53-002, For In Vitro Diagnostic UseZ-0268-2023 · OOIAbbott Molecular, Inc.RecallNov 18, 2022FDA classification date
Architect CMV IgGK220949 · LFZAbbott Laboratories510(k)Oct 27, 2022FDA decision date
Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use.Z-1679-2022 · QJRAbbott Molecular, Inc.RecallSep 6, 2022FDA record creation date
ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27Z-1660-2022 · MMIAbbott LaboratoriesRecallAug 30, 2022FDA record creation date
The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Z-1518-2022 · MZPAbbott Molecular, Inc.RecallAug 12, 2022FDA record creation date
REF: 4P52-20 Hemoglobin A1c for use with Architect, IVD, CE, R1 1 x 52 mL, R2 1 x 20 mL, A1cDL 2 x 35 mLZ-1454-2022 · PDJAbbott LaboratoriesRecallJul 22, 2022FDA record creation date
REF: 08P4320, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLZ-1455-2022 · PDJAbbott LaboratoriesRecallJul 22, 2022FDA record creation date
REF: 08P4377, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLZ-1456-2022 · PDJAbbott LaboratoriesRecallJul 22, 2022FDA record creation date
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)K212778 · QLXAbbott Molecular, Inc.510(k)Jul 15, 2022FDA decision date
FreeStyle Libre 3 Continuous Glucose Monitoring SystemK212132 · QLGAbbott Diabetes Care, Inc.510(k)May 26, 2022FDA decision date
FreeStyle Libre 3 Continuous Glucose Monitoring SystemK213996 · QLGAbbott Diabetes Care, Inc.510(k)May 26, 2022FDA decision date
ARCHITECT Toxo IgGK210596 · LGDAbbott Laboratories510(k)May 19, 2022FDA decision date
Alinity m STI AssayK202977 · QEPAbbott Molecular, Inc.510(k)Apr 29, 2022FDA decision date
ARCHITECT STAT Myoglobin Calibrators, RES 2K43-01 The ARCHITECT STAT Myoglobin Calibrators are for the calibration of the ARCHITECT iSystem with…Z-0891-2022 · JISAbbott LaboratoriesRecallApr 7, 2022FDA record creation date
Alinity m HBV Application Specification File (US and CE)Z-0883-2022 · MKTAbbott Molecular, Inc.RecallApr 6, 2022FDA classification date
Alinity m HBV AMP Kit (US and CE)Z-0884-2022 · MKTAbbott Molecular, Inc.RecallApr 6, 2022FDA classification date
Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗